BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32560738)

  • 1. Diverse proteins aggregate in mild cognitive impairment and Alzheimer's disease brain.
    Kepchia D; Huang L; Dargusch R; Rissman RA; Shokhirev MN; Fischer W; Schubert D
    Alzheimers Res Ther; 2020 Jun; 12(1):75. PubMed ID: 32560738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass Spectrometry.
    Zaman M; Fu Y; Chen PC; Sun H; Yang S; Wu Z; Wang Z; Poudel S; Serrano GE; Beach TG; Li L; Wang X; Peng J
    Mol Cell Proteomics; 2023 Aug; 22(8):100608. PubMed ID: 37356496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease.
    Gozal YM; Duong DM; Gearing M; Cheng D; Hanfelt JJ; Funderburk C; Peng J; Lah JJ; Levey AI
    J Proteome Res; 2009 Nov; 8(11):5069-79. PubMed ID: 19746990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum.
    Paciotti S; Wojdała AL; Bellomo G; Toja A; Chipi E; Piersma SR; Pham TV; Gaetani L; Jimenez CR; Parnetti L; Chiasserini D
    Alzheimers Res Ther; 2023 Jul; 15(1):124. PubMed ID: 37454217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.
    Mukherjee S; Dubois C; Perez K; Varghese S; Birchall IE; Leckey M; Davydova N; McLean C; Nisbet RM; Roberts BR; Li QX; Masters CL; Streltsov VA
    J Neurochem; 2023 Feb; 164(4):529-552. PubMed ID: 36271678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
    Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain.
    Wildburger NC; Esparza TJ; LeDuc RD; Fellers RT; Thomas PM; Cairns NJ; Kelleher NL; Bateman RJ; Brody DL
    Sci Rep; 2017 Aug; 7(1):9520. PubMed ID: 28842697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons.
    Gal J; Chen J; Katsumata Y; Fardo DW; Wang WX; Artiushin S; Price D; Anderson S; Patel E; Zhu H; Nelson PT
    J Neuropathol Exp Neurol; 2018 Jan; 77(1):21-39. PubMed ID: 29186589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.
    Kang S; Jeong H; Baek JH; Lee SJ; Han SH; Cho HJ; Kim H; Hong HS; Kim YH; Yi EC; Seo SW; Na DL; Hwang D; Mook-Jung I
    J Alzheimers Dis; 2016 Jul; 53(4):1563-76. PubMed ID: 27392853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.
    Diner I; Nguyen T; Seyfried NT
    J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer's disease.
    Tremblay C; Pilote M; Phivilay A; Emond V; Bennett DA; Calon F
    J Alzheimers Dis; 2007 Dec; 12(4):377-90. PubMed ID: 18198424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Quantification of Detergent-Insoluble RNA-Binding Proteins in Human Brain Reveals Stage and Disease Specific Co-aggregation in Alzheimer's Disease.
    Guo Q; Dammer EB; Zhou M; Kundinger SR; Gearing M; Lah JJ; Levey AI; Shulman JM; Seyfried NT
    Front Mol Neurosci; 2021; 14():623659. PubMed ID: 33815056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease.
    Woltjer RL; Duerson K; Fullmer JM; Mookherjee P; Ryan AM; Montine TJ; Kaye JA; Quinn JF; Silbert L; Erten-Lyons D; Leverenz JB; Bird TD; Pow DV; Tanaka K; Watson GS; Cook DG
    J Neuropathol Exp Neurol; 2010 Jul; 69(7):667-76. PubMed ID: 20535038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease.
    Woltjer RL; Cimino PJ; Boutté AM; Schantz AM; Montine KS; Larson EB; Bird T; Quinn JF; Zhang J; Montine TJ
    FASEB J; 2005 Nov; 19(13):1923-5. PubMed ID: 16129700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citrullination of Amyloid-β Peptides in Alzheimer's Disease.
    Mukherjee S; Perez KA; Dubois C; Nisbet RM; Li QX; Varghese S; Jin L; Birchall I; Streltsov VA; Vella LJ; McLean C; Barham KJ; Roberts BR; Masters CL
    ACS Chem Neurosci; 2021 Oct; 12(19):3719-3732. PubMed ID: 34519476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
    Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
    Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive temporal profiles of detergent-soluble and -insoluble tau and Aβ species in human Alzheimer's disease.
    Koss DJ; Dubini M; Buchanan H; Hull C; Platt B
    Brain Res; 2018 Nov; 1699():121-134. PubMed ID: 30102892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer disease.
    Diner I; Hales CM; Bishof I; Rabenold L; Duong DM; Yi H; Laur O; Gearing M; Troncoso J; Thambisetty M; Lah JJ; Levey AI; Seyfried NT
    J Biol Chem; 2014 Dec; 289(51):35296-313. PubMed ID: 25355317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach.
    Begcevic I; Brinc D; Brown M; Martinez-Morillo E; Goldhardt O; Grimmer T; Magdolen V; Batruch I; Diamandis EP
    J Proteomics; 2018 Jun; 182():12-20. PubMed ID: 29684683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.